XML 20 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
OPERATING ACTIVITIES        
Net income $ 871.2 $ 508.1 $ 2,574.8 $ 985.2
Adjustments to reconcile net earnings to net cash provided from operating activities:        
Depreciation, amortization and depletion 203.4 196.0 599.4 582.8
Equity earnings of affiliate, net of dividends received 2.8 (3.1) (6.3) (3.9)
(Gain) loss on foreign currency transaction effect (36.6) 4.1 (50.0) (24.8)
Benefit for deferred income taxes (103.3) (45.9) (100.1) (57.2)
Other, net 5.1 4.2 16.9 15.2
Change in operating assets and liabilities:        
Increase in accounts receivable (57.7) (101.6) (424.5) (122.6)
(Increase) decrease in inventories (9.5) (0.6) (8.3) 155.8
Increase in accounts payable and accrued liabilities 332.3 268.2 409.5 99.3
Decrease (increase) in other operating assets and liabilities 12.9 (35.9) 53.3 58.2
Net cash provided by operating activities 1,220.6 793.5 3,064.7 1,688.0
INVESTING ACTIVITIES        
Capital expenditures (243.1) (134.5) (695.5) (348.8)
Proceeds from (purchase) sale of short-term investments, net (81.0)   (216.0) 50.0
Other 9.9 0.8 (0.6) 1.2
Net cash used in investing activities (314.2) (133.7) (912.1) (297.6)
FINANCING ACTIVITIES        
Repayments of debt       (400.0)
Capitalization of debt issuance cost       0.1
Cash dividends paid to common stockholders (695.8) (309.2) (1,700.8) (773.1)
Other, net (1.6) 0.3 (4.3) (2.1)
Net cash used in financing activities (697.4) (308.9) (1,705.1) (1,175.1)
Effect of exchange rate changes on cash and cash equivalents (19.6) (14.3) (47.4) 5.0
Increase in cash and cash equivalents 189.4 336.6 400.1 220.3
Cash and cash equivalents, at beginning of period 2,394.3 1,808.8 2,183.6 1,925.1
Cash and cash equivalents, at end of period $ 2,583.7 $ 2,145.4 $ 2,583.7 $ 2,145.4